Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national surveyResearch in context

• Main Authors: Nobuaki Nakano (Author), Hideki Nakasone (Author), Shigeo Fuji (Author), Akihito Shinohara (Author), Ritsuro Suzuki (Author), Atae Utsunomiya (Author), Tetsuya Eto (Author), Satoko Morishima (Author), Kazuhiro Ikegame (Author), Yasutaka Kakinoki (Author), Ken-ichi Matsuoka (Author), Yasuo Mori (Author), Youko Suehiro (Author), Naoyuki Uchida (Author), Ayumu Ito (Author), Noriko Doki (Author), Yukiyasu Ozawa (Author), Junya Kanda (Author), Yoshinobu Kanda (Author), Takahiro Fukuda (Author), Yoshiko Atsuta (Author), Masao Ogata (Author)
• Format: Book
• Published: Elsevier, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Human T-cell leukemia virus type I (HTLV-1) is a retrovirus known to cause adult T-cell leukemia/lymphoma (ATL). There are few reports on hematopoietic stem cell transplantation (HSCT) for d HTLV-1 carriers with diseases other than ATL. Methods: A total of 25,839 patients (24,39...